Feedback PLC
LSE:FDBK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Feedback PLC
Research & Development
Feedback PLC
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Feedback PLC
LSE:FDBK
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Renalytix PLC
LSE:RENX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Craneware PLC
LSE:CRW
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cambridge Cognition Holdings PLC
LSE:COG
|
Research & Development
-£2.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Doctor Care Anywhere Group PLC
ASX:DOC
|
Research & Development
-£3.7m
|
CAGR 3-Years
20%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
P
|
Physitrack PLC
STO:PTRK
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Feedback PLC
Glance View
Feedback Plc operates as an investing company, which seeks to acquire a direct interest in one or more companies in the technology sector. The principal activity of the Company is the development and commercialization of its technologies, including Bleepa, the image-based communication platform for frontline clinicians; CareLocker, the patientcentric cloud architecture, and Bleepa Box, store and forward technology. The company offers TexRAD, which provides radiologists, clinicians and medical researchers with a non-invasive imaging biomarker. Its TexRAD’s algorithm extracts and quantifies texture features in pre-existing medical images. These texture features are used to demonstrate diagnostic, prognostic and predictive intelligence in scientific research with particular focus in oncology. The company offers Cadran, a suite of picture archiving storage, management and display system for medical images. The company also provides consultancy services for medical image management within organizations. The company offers TexRAD Lung, a software tool for the analysis of lung cancer.
